Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
TtbioROCO:6493 -5.15%60 FCF Yield % is -3.41 as of Jul. 15, 2026. GuruFocus rates ROCO:6493 with a GF Score™ of 60/100 and a GF Value™ of NT$19.62 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 855 Medical Devices & Instruments companies, Ttbio ranks worse than 60.94% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
As of today, Ttbio's Trailing 12-Month Free Cash Flow is NT$-50.0 Mil, and Market Cap is NT$1,467.9 Mil. Therefore, Ttbio's FCF Yield % for today is -3.41%.
The historical rank and industry rank for Ttbio's FCF Yield % or its related term are showing as below:
ROCO:6493'
s FCF Yield % Range Over the Past 10 Years
Min: -8.4 Med: 1.33 Max: 8.43
Current: -3.41
During the past 13 years, the highest FCF Yield % of Ttbio was 8.43%. The lowest was -8.40%. And the median was 1.33%.
ROCO:6493's FCF Yield % is ranked worse than 60.94% of 855
companies
in the Medical Devices & Instruments industry
Industry Median: -0.43
vs ROCO:6493: -3.41
Ttbio's FCF Margin % for the quarter that ended in Dec. 2025 was -24.61%.
Ttbio FCF Yield % Explanation
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
Ttbio FCF Yield % Related Terms
Ttbio FCF Yield % Historical Data
* Premium members only.
The historical data trend for Ttbio's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ROCO:6493 vs ISRG, BDX, MDLN: FCF Yield % Comparison
For the Medical Instruments & Supplies subindustry, Ttbio's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Ttbio FCF Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Ttbio's FCF Yield % distribution charts can be found below:
* The bar in red indicates where Ttbio's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Ttbio (ROCO:6493) has a FCF Yield % of -3.41 as of Jul. 15, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ttbio and its competitors. According to the industry distribution chart, Ttbio ranks #521 out of 855 companies in the Medical Devices & Instruments industry, placing it in the top 60.9%.
Is Ttbio's FCF Yield % too high?
Ttbio's current FCF Yield % is -3.41. Based on the distribution chart, Ttbio ranks #521 out of 855 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Ttbio has a GF Score™ of 60/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Ttbio's FCF Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Ttbio ranks #521 out of 855 companies for FCF Yield %. This places Ttbio in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Medical Devices & Instruments company?
A good FCF Yield % depends on the Medical Devices & Instruments industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Ttbio and its competitors. Ttbio's current FCF Yield % is -3.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ttbio stock overvalued right now?
Based on GuruFocus' analysis, Ttbio (ROCO:6493) is currently considered Significantly Overvalued. The stock's GF Value™ is NT$19.62, compared to a current price of NT$48.85 — trading 149% above its estimated fair value. The current FCF Yield % is -3.41. Ttbio's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For Ttbio (ROCO:6493), the current FCF Yield % is -3.41 as of Jul. 15, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Ttbio (ROCO:6493) Overvalued in 2026?
Based on GuruFocus' analysis, Ttbio stock appears to be overvalued.
The current stock price of NT$48.85 is trading 149% above its estimated GF Value™ of NT$19.62.
GuruFocus considers Ttbio to be Significantly Overvalued.
Key valuation signals for ROCO:6493:
FCF Yield %: -3.41
GF Value™: NT$19.62 vs. price of NT$48.85 (149% above fair value)
No single metric tells the full story. See the ROCO:6493 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Ttbio Corp is a Taiwan based company engaged in the manufacturing of dental products and accessories. Its products include High-Speed Handpiece Series, Low-Speed Handpiece Series, Dental Spare Parts, Service Rotor, and Maintenance Unit among others.
60GF Score
Get the complete analysis for ROCO:6493
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ROCO:6493 has been successfully added to your 
